Report Overview: The Global Newborn Screening Market achieved a valuation of $785.86 Million in 2022 and is anticipated to exceed $1433.19 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 7.8% during the forecast period from 2024 to 2032. Key Market Players: PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher...